Biogen's Q4 2024 earnings showed slight revenue growth but Wall Street remains unimpressed due to weak guidance and declining key drug franchises. Leqembi's commercial performance is disappointing ...

Biogen expects full-year 2025 total revenue to decline by a mid-single digit percentage. The company’s stock was down about 6% at 10 a.m. on Wednesday with shares priced at around $131 apiece.

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

If you’re not yet using a collagen supplement, let this be your sign to start. If you already know about collagen’s function in the body – it’s the single most prolific protein that provides tissues ...

Nicole Gregory is an editor and writer in Los Angeles who has contributed to the Los Angeles Times, the Orange County Register, Vegetarian Times, Good Housekeeping, Family Circle, New Woman and ...

If enrollment in Medicare is on the horizon for you or a loved one, it’s also worth looking into Medicare Supplement insurance, commonly known as Medigap. Read on to learn more about your health ...

As registered dietitian and founder of Chelsea Nutrition Jennifer Maeng says, you can think of multivitamins as an “insurance policy” that can supplement dietary blind spots. Amy Shapiro ...